# EXSERVAN
> **NDA212640** · New Drug Application · Sponsor: AQUESTIVE · Approved 2019-11-22
## Drug
- **FDA Application Number:** NDA212640
- **Application type:** New Drug Application
- **Brand name:** EXSERVAN
- **Generic name:** Riluzole
- **Active ingredients:** RILUZOLE
- **Dosage form:** FILM
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** AQUESTIVE
- **First approval:** 2019-11-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212640)
---
*MORVS · CC0 1.0*